Filing Details

Accession Number:
0001181431-15-000537
Form Type:
4
Zero Holdings:
No
Publication Time:
2015-01-06 19:35:15
Reporting Period:
2014-01-02
Filing Date:
2015-01-06
Accepted Time:
2015-01-06 19:35:15
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
927066 Davita Healthcare Partners Inc. DVA Services-Misc Health & Allied Services, Nec (8090) 510354549
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1604063 David Michael Staffieri C/O Davita Healthcare Partners Inc.
2000 16Th Street
Denver CO 80202
Coo, Kidney Care No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2015-01-02 17,000 $31.70 17,000 No 4 M Direct
Common Stock Disposition 2015-01-02 7,116 $75.74 9,884 No 4 F Direct
Common Stock Disposition 2015-01-02 9,884 $75.52 0 No 4 S Direct
Common Stock Acquisiton 2015-01-02 80,000 $34.52 80,000 No 4 M Direct
Common Stock Disposition 2015-01-02 36,457 $75.74 43,543 No 4 F Direct
Common Stock Disposition 2015-01-02 43,543 $75.83 0 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 M Direct
No 4 F Direct
No 4 S Direct
No 4 M Direct
No 4 F Direct
No 4 S Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Stock Appreciation Rights Disposition 2015-01-02 17,000 $0.00 17,000 $31.70
Common Stock Stock Appreciation Rights Disposition 2015-01-02 80,000 $0.00 80,000 $34.52
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
0 2012-03-31 2015-03-31 No 4 M Direct
40,000 2011-09-30 2015-09-30 No 4 M Direct
Footnotes
  1. The sales reported on this Form 4 were affected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 18, 2014.
  2. Represents the weighted average sale price of $75.5242. The range of prices for the sale of these shares was $75.47 - $75.60, rounded to the nearest hundredths. The reporting person undertakes to provide upon request by the Commission staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares purchased or sold at each separate price.
  3. Represents the weighted average sale price of $75.8282. The range of prices for the sale of these shares was $75.60 - $76.31, rounded to the nearest hundredths. The reporting person undertakes to provide upon request by the Commission staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares purchased or sold at each separate price.
  4. Stock Appreciation Rights, granted on 3/31/10, pursuant to the DaVita Inc. 2002 Equity Compensation Plan, (as amended and restated, the "DaVita HealthCare Partners Inc. 2011 Incentive Award Plan," effective June 6, 2011), which vested 33.3% on the second anniversary of the grant date, and 8.33% every 3 months thereafter.
  5. Stock Appreciation Rights, granted on 9/30/2010, pursuant to the DaVita Inc. 2002 Equity Compensation Plan, (as amended and restated, the "DaVita HealthCare Partners Inc. 2011 Incentive Award Plan," effective June 6, 2011), which vested 25% on the first anniversary of the grant date, then 6.25% every three months thereafter.